ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
ECONOMIC BURDEN AND REAL-WORLD EVIDENCE OF MATERNAL HEALTH SERVICE DISRUPTIONS IN CONFLICT-AFFECTED SAHELIAN NIGERIA
Mar 6, 2026, 15:54 PM -
WHAT DOES A “SOCIETAL PERSPECTIVE” INCLUDE IN PRACTICE? A SYSTEMATIC ANALYSIS OF ICER ASSESSMENTS IN ULTRA-RARE DISEASES
Mar 6, 2026, 15:54 PM -
A BREATHTAKING GAP IN THE SOCIAL COST OF CARBON: VALUING HEALTH LOSSES FROM CLIMATE CHANGE
Mar 6, 2026, 15:54 PM -
A MULTI-COUNTRY LIFETIME COST ANALYSIS OF HIV IN 10 LATIN AMERICA COUNTRIES: ARGENTINA, CHILE, COSTA RICA, ECUADOR, EL SALVADOR, GUATEMALA, PANAMA, PERU, URUGUAY, PARAGUAY
Mar 6, 2026, 15:54 PM -
BENCHMARKING GENERATIVE AI TOOLS FOR COST-EFFECTIVENESS ANALYSIS (CEA) MODEL INPUT CURATION: A COMPARATIVE EVALUATION OF LARGE LANGUAGE MODELS
Mar 6, 2026, 15:53 PM -
OPENING THE BLACK BOX: A HUMAN-GOVERNED AGENTIC AI FRAMEWORK FOR HEALTH ECONOMIC MODELING
Mar 6, 2026, 15:53 PM -
ECONOMIC VALUE OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSIS HIGHLIGHTING METHODOLOGICAL GAPS
Mar 6, 2026, 15:53 PM -
LIVING SYSTEMATIC REVIEWS (LSRS) AND ARTIFICIAL INTELLIGENCE (AI) IN THE EUROPEAN JOINT CLINICAL ASSESSMENT (JCA) ERA: ALIGNMENT AND GAPS ACROSS PRISMA, COCHRANE, ISPOR, AND HEALTH TECHNOLOGY ASSESSMENT (HTA) GUIDANCE
Mar 6, 2026, 15:53 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF THE TRIVALENT ADJUVANTED INFLUENZA VACCINE IN PEOPLE OVER 50 YEARS OF AGE FOR ARGENTINA
Mar 6, 2026, 15:52 PM -
MOTHERS’ WILLINGNESS TO PAY FOR CHILDHOOD VACCINATION IN TANZANIA: EVIDENCE FROM A TWO-PART INTERVAL REGRESSION MODEL WITH EQUITY IMPLICATION
Mar 6, 2026, 15:52 PM -
ECONOMIC EVALUATIONS AND VALUE CONSIDERATIONS IN ACIP ROUTINE VACCINE RECOMMENDATIONS: A COMPREHENSIVE REVIEW
Mar 6, 2026, 15:52 PM -
CONSIDERATION OF INDIRECT EFFECTS IN NATIONAL VACCINE EVALUATIONS AND RECOMMENDATIONS: A SCOPING REVIEW
Mar 6, 2026, 15:52 PM -
POTENTIAL ENVIRONMENTAL AND ECONOMIC IMPLICATIONS OF ROBOTIC ASSISTED SURGERY FOR UROLOGIC ONCOLOGY
Mar 6, 2026, 15:51 PM -
DECISION-RELEVANT EARLY HEALTH ECONOMIC MODELLING TO INFORM DEVELOPMENT AND INVESTMENT IN EMERGING HEALTH TECHNOLOGIES
Mar 6, 2026, 15:51 PM -
DEVELOPMENT OF THE MEDICAL DEVICE ECONOMIC EVALUATION METHODOLOGICAL QUALITY (DEEM-Q) CHECKLIST
Mar 6, 2026, 15:51 PM -
BUDGET IMPACT OF ADOPTING A TRI-LAYER HYBRID SURGICAL MESH FOR VENTRAL HERNIA REPAIR: A U.S. HOSPITAL PERSPECTIVE
Mar 6, 2026, 15:51 PM -
HEALTH RELATED QUALITY OF LIFE (HRQOL) REPORTING IN ADULTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) RISK STRATIFIED BY MULTIPARAMETRIC MRI (MPMRI)
Mar 6, 2026, 15:51 PM -
DEVELOPMENT AND EXTERNAL VALIDATION OF A NOVEL COPULA-BASED METHOD FOR CROSS-COUNTRY EQ-5D UTILITY VALUE CONVERSION
Mar 6, 2026, 15:51 PM -
APPLICATION OF MAPPING ALGORITHMS FOR THE PEDIATRIC QUALITY OF LIFE INVENTORY GENERIC CORE SCALES (PEDSQL GCS) TO THE EUROQOL 5 DIMENSIONS (EQ-5D) UTILITIES IN CHILDHOOD CANCER SURVIVORS IN JAPAN
Mar 6, 2026, 15:51 PM -
EMPIRICAL VALIDITY OF CANADIAN-WEIGHTED HEALTH UTILITIES FOR THE VR-12 IN PATIENTS WITH LIFE-LIMITING ILLNESS AND THEIR FAMILY CAREGIVERS
Mar 6, 2026, 15:51 PM